AbbVie has agreed a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will give it control of a preclinical-stage, oral drug for psoriasis. US-based Nimble was set up in ...
AbbVie has secured its fourth FDA approval for Vraylar, adding adjunctive therapy of major depressive disorder (MDD) to a list that includes schizophrenia and manic and depressive episodes in ...
**NM signifies a non meaningful value. A dash signifies the data is not available.
Pre-Market: 4:48:57 a.m. EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback